Beauty Health Co (SKIN) Annual Income Statement (USD)
SKIN Quarterly Financials (USD)
Frequently Asked Questions About Beauty Health Co (SKIN) Stock
Beauty Health Co's (SKIN) last reported annual revenue was USD 397.99 Million.
Beauty Health Co's (SKIN) annual revenue growth rate based on the revenue reported in the past 5 years is : 28.79%
Beauty Health Co's(SKIN) is not profitable as of its last reported annual financials.
The net profit margin for Beauty Health Co's(SKIN) from its laster reported year is -25.16%
The return on equity (ROE) for Beauty Health Co's(SKIN) from its last reported annual financials is : -88.43%
The return on assets (ROA) for Beauty Health Co's(SKIN) from its last reported annual financials is : -8.47%
The return on invested capital (ROIC) for Beauty Health Co's(SKIN) from its last reported annual financials is : -14.32%
The Debt to Equity ratio for Beauty Health Co's(SKIN) from its last reported annual financials is : 1243.26%
The dividend yield for Beauty Health Co's(SKIN) from its laster reported year is 0.00%
Beauty Health Co's(SKIN) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SKIN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
